Aarti Drugs has recently expanded its anti-diabetic capacity and currently scaling up its production quantities for the same. Further, brown field CAPEX would be done in the current financial year to expand few capacities in anti-inflammatory therapeutic category.
Aarti Drugs is engaged in the business of manufacturing generic bulk actives, advanced intermediates and specialty chemicals.